Finoriq research workspace
Medtronic plc (MDT) SEC Filings & Filing Highlights
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare. Review MDT SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.
- Company
- Medtronic plc (MDT)
- Ticker
- MDT
- Market Cap
- $106.9B
- Latest Price
- $83.5
- Industry
- Medical Devices
Medtronic plc (MDT) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for Medtronic plc (MDT).
| Event | Form | Date |
|---|---|---|
| Medtronic reports fourth quarter and full year fiscal 2026 results; delivers highest annual rev...Medtronic reports fourth quarter and full year fiscal 2026 results; delivers highest annual revenue growth in 10 years | 8-K2.02 | 2026-06-03 |
| On May 18, 2026, Medtronic plc (“Medtronic” or the “Company”) announced that Brett Wall will be...On May 18, 2026, Medtronic plc (“Medtronic” or the “Company”) announced that Brett Wall will be departing from his position as Executive Vi... | 8-K5.02 | 2026-05-18 |
| Medtronic statement on unauthorized system accessMedtronic statement on unauthorized system access | 8-K7.01 | 2026-04-27 |
| Non-GAAP financial measuresOn March 18, 2026, MiniMed Group, Inc. (MiniMed), a consolidated subsidiary of Medtronic plc (Company) announced that the U.S. Food and Dru... | 8-K7.01 | 2026-03-24 |
| Medtronic reports strong third quarterfiscal 2026 results with highest enterprise revenue growth in 10 quarters | 8-K2.02 | 2026-02-17 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.